SPY336.83-0.61 -0.18%
DIA279.42-0.62 -0.22%
IXIC11,042.50+30.27 0.27%

BMO Capital Maintains Outperform on Chemours, Raises Price Target to $25

BMO Capital maintains Chemours (NYSE:CC) with a Outperform and raises the price target from $23 to $25.

Benzinga · -

BMO Capital maintains Chemours (NYSE:CC) with a Outperform and raises the price target from $23 to $25.